Stereotaxis, Inc. Common Stock (STXS)
2.3800
+0.0600 (2.59%)
NYSE · Last Trade: Dec 16th, 5:05 PM EST
Detailed Quote
| Previous Close | 2.320 |
|---|---|
| Open | 2.370 |
| Bid | 2.380 |
| Ask | 2.410 |
| Day's Range | 2.370 - 2.420 |
| 52 Week Range | 1.540 - 3.590 |
| Volume | 670,424 |
| Market Cap | 222.11M |
| PE Ratio (TTM) | -8.500 |
| EPS (TTM) | -0.3 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 426,206 |
Chart
About Stereotaxis, Inc. Common Stock (STXS)
Stereotaxis Inc is a medical device company that specializes in advanced robotic systems for the cardiovascular catheterization market. The company's innovative technologies focus on enhancing the precision and effectiveness of minimally invasive procedures, particularly in the treatment of arrhythmias and other heart conditions. By integrating advanced robotics and navigation systems, Stereotaxis aims to improve the outcomes of electrophysiological procedures, enabling physicians to perform complex interventions with greater safety and efficiency. Their commitment to innovation and patient care positions them as a leader in the evolving landscape of cardiac treatments. Read More
News & Press Releases
Via Benzinga · November 12, 2025
Stereotaxis stock fell sharply after Q3 2025 results, as a 13% revenue miss overshadowed a smaller-than-expected quarterly loss.
Via Chartmill · November 11, 2025
Via Benzinga · November 11, 2025
Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endovascular interventions.
Via Benzinga · September 22, 2025
Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement.
Via Chartmill · August 7, 2025
Stereotaxis shares are moving higher on Wednesday after the company announced it was accepted into the NVIDIA Connect program.
Via Benzinga · March 19, 2025

STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · June 18, 2024

STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via InvestorPlace · April 19, 2024

These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.
Via InvestorPlace · April 10, 2024

Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
Via InvestorPlace · March 17, 2024

Via Benzinga · March 4, 2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.
Via Benzinga · March 4, 2024

Via Benzinga · January 12, 2024

